share_log

Jefferies Adjusts Kissei Pharmaceutical's Price Target to 3,600 Yen From 3,400 Yen, Keeps at Hold

Jefferies Adjusts Kissei Pharmaceutical's Price Target to 3,600 Yen From 3,400 Yen, Keeps at Hold

Jefferies將鳴志製藥的目標股價從3400日元上調至3600日元,持有評級不變。
MT Newswires ·  07/30 05:26  · 評級/大行評級

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論